Key Takeaways Carlyle will collaborate with Citigroup to grow asset-backed finance in fintech specialty lending. The partnership unites Carlyle's investment reach with Citigroup's SPRINT fintech expertise. Both firms will share market insights and co-invest to meet the rising fintech lender funding demand.Carlyle Group Inc. (CG) has announced a collaboration with Citigroup Inc. (C) to expand asset-backed financing opportunities within the fintech specialty lending space.Details of the Partnership Between ...

When last I wrote about C4 Therapeutics (NASDAQ: CCCC ) a few months ago , my headline stated that the stock is getting "too cheap to ignore," but this did not ascend toI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this space.Analyst’s Disclosure ...

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong candidates involves navigating inherent risks and volatility [1] Group 1: Company Overview - New Jersey Resources (NJR) is currently highlighted as a promising growth stock, supported by a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 9.6%, with projected EPS growth of 9.9% this year, surpassing the industry average of 9.2% [4] Group 2: Financial Metrics - NJR's year-over-year cash flow growth stands at 10.3%, significantly higher than the industry average of -0.1% [5] - The historical annualized cash flow growth rate for NJR over the past 3-5 years is 12.3%, compared to the industry average of 7.2% [6] Group 3: Earnings Estimates - There is a positive trend in earnings estimate revisions for NJR, with the current-year earnings estimates increasing by 0.8% over the past month [7] - NJR has achieved a Zacks Rank of 2 (Buy) due to favorable earnings estimate revisions and a Growth Score of B [8] Group 4: Investment Potential - The combination of strong growth metrics and positive earnings revisions positions NJR well for potential outperformance, making it an attractive option for growth investors [9]

Group 1 - Permian Resources announced another acquisition during the first quarter earnings press release, indicating ongoing growth and expansion strategies [2] - The revised guidance provided by Permian Resources did not account for the latest acquisition, suggesting potential for further adjustments in future forecasts [2] - The oil and gas industry is characterized as a boom-bust, cyclical sector, requiring patience and experience for successful investment [2] Group 2 - The analysis of oil and gas companies focuses on identifying undervalued names within the sector, examining balance sheets, competitive positions, and development prospects [1] - Members of the Oil & Gas Value Research service receive early access to analyses and insights that are not available on the free site [1]

Core Insights - SkyWater Technology's Wafer Services revenues experienced a 25% year-over-year decline in Q1 FY25 due to decreased demand from automotive customers, but a strong sequential rebound of 70% to $7.5 million was driven by the launch of the ThermaView platform [2][9] - ThermaView, SkyWater's first internally developed product platform for thermal imaging, is already being deployed by two major U.S. defense contractors, indicating its significance in mission-critical applications [3][9] - The company anticipates that ThermaView will be a key growth driver for Wafer Services through FY25, addressing a projected $9 billion market opportunity by 2027 [4][5] Financial Performance - For Q2 FY25, SkyWater expects Wafer Services revenues to be between $5 million and $6 million, reflecting ongoing demand for ThermaView [4][9] - SkyWater's shares have declined by 40.6% year-to-date, contrasting with the Zacks Electronics – Semiconductors industry's return of 3.9% [8] - The current forward 12-month price-to-sales ratio for SkyWater is 1.17, significantly lower than the industry average of 8X, making it an attractive option for value investors [10] Earnings Estimates - The Zacks Consensus Estimate for SkyWater's 2025 loss is currently at 1 cent per share, which has narrowed by 85.7% over the past 60 days, indicating a year-over-year decline of 116.67% [11] - Earnings estimates for the upcoming quarters show a projected loss of $0.17 for the current quarter, a profit of $0.09 for the next quarter, and a loss of $0.01 for the current year [12] Competitive Landscape - SkyWater faces significant competition from GlobalFoundries, which offers a wide range of process technologies and serves diverse markets, holding advantages in scale and capacity [6] - Tower Semiconductor specializes in analog, RF, and MEMS technologies, targeting high-value niches and offering customizable solutions, which positions it as a strong competitor in complex analog projects [7]

Key Takeaways SKYT is gaining traction through new tech platforms, quantum projects and the Fab 25 acquisition plan. SKYT's forward P/S of 1.17X and value score of B make it attractive versus MRVL's 6.61X and value score of D. MRVL faces margin pressure from lower-margin custom silicon and softness in industrial segments.SkyWater Technology (SKYT) and Marvell Technology (MRVL) are both active players in the semiconductor space, with SKYT focusing on specialty foundry services and MRVL leading in custom si ...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Vestis Corporation (NYSE: VSTS) between May 2, 2024 and May 6, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2025. SO WHAT: If you purchased Vestis securities during the Class Period yo ...

Core Insights - Novo Nordisk (NVO) shares have increased by 5.8% in a week due to an activist hedge fund, Parvus Asset Management, acquiring a stake and a positive update on the obesity candidate amycretin [1][11] - The company is advancing amycretin into late-stage development, with plans to initiate the phase III program in Q1 2026 [2] - Novo Nordisk is expanding its obesity pipeline to maintain its market leadership amid rising competition from Eli Lilly and others [3][11] Company Developments - CVS Caremark has made Wegovy, Novo Nordisk's weight-loss drug, its preferred GLP-1 therapy for weight loss, effective July 1, enhancing NVO's competitive position [4] - The company is focusing on next-generation drugs for obesity, including CagriSema and monlunabant, with significant investments in manufacturing capacity [12][13] - Recent setbacks in the pipeline have led to a 26.1% decline in stock price over the past six months, despite recent recovery [14] Market Position - Novo Nordisk holds a 33.3% share in the global diabetes market and a 54% share in the GLP-1 segment as of Q1 2025 [7] - Wegovy revenues surged by 83% to DKK 17.4 billion in Q1 2025, driven by strong prescription growth [8] - The obesity market is projected to reach $100 billion by 2030, intensifying competition from companies like Eli Lilly, Amgen, and Viking Therapeutics [16][17] Financial Performance - Year-to-date, Novo Nordisk shares have decreased by 7.2%, underperforming the industry and S&P 500 [18] - The stock is currently trading at a price/earnings ratio of 18.99, higher than the industry average of 15.64, but below its five-year mean of 29.25 [20] - Earnings estimates for 2025 and 2026 have improved slightly, indicating potential for future growth [25] Strategic Outlook - The company is actively working on expanding the indications for its semaglutide products, which could significantly increase the patient pool and drive future revenues [32] - Despite past setbacks, the company is viewed as having long-term potential due to strong revenue growth from its key products [31][32] - Investors are advised to hold positions for long-term gains, while short-term investors may want to avoid the stock due to volatility [33]

BofA Securities analyst Michael Feniger maintained a Buy Rating on Caterpillar, Inc. CAT on Monday, with a price target of $385.Caterpillar’s Energy & Transportation (E&T) segment contributes about 40% of sales to overall to the company, Feniger noted.Given its diverse portfolio, it’s also the least-understood segment within Caterpillar, he added.Also Read: BofA Securities Stays Bullish On Caterpillar: ‘Surprisingly Durable’ US Economy, Global MomentumCaterpillar’s E&T segment is expected to drive the compa ...

Core Insights - Ralph Lauren Corporation (RL) and PVH Corporation (PVH) are significant players in the Textile-Apparel industry, each with unique strategies and brand identities [1][2] - Both companies are adapting to evolving global consumer demands through digital innovation, supply chain agility, and direct-to-consumer expansion [2][3] Ralph Lauren (RL) Overview - Ralph Lauren is focusing on brand elevation, geographic diversification, and personalized promotions to support growth and cost management [4][5] - The company anticipates low-single-digit revenue growth in constant currency for fiscal 2026, with stronger momentum expected in the first half [6] - Gross margin is projected to remain flat, with AUR growth and lower cotton costs offsetting headwinds from higher tariffs [7] - RL's fiscal 2026 sales and EPS are expected to grow by 3.5% and 10.9% year-over-year, respectively [13] PVH Overview - PVH holds a dominant position in the premium and lifestyle apparel industry, with a diversified business model that includes direct-to-consumer, wholesale, and licensing [8][9] - The company is advancing its PVH+ Plan, focusing on brand elevation, digital acceleration, and operational efficiency, but faces macro pressures and shipment delays [10][12] - PVH's fiscal 2025 sales are projected to grow by 1.4%, while EPS is expected to decline by 5.9% [16] Stock Performance and Valuation - RL is trading at a forward price-to-earnings multiple of 18.65X, significantly higher than the industry average of 11.22X, while PVH trades at a multiple of 5.55 [18] - Ralph Lauren's stock has gained 18.2% in the past three months, outperforming PVH and the broader industry [21] - Despite PVH's strong brand portfolio, its discounted valuation may reflect limited near-term visibility amid ongoing macroeconomic headwinds [19] Conclusion - RL is positioned as a stronger contender in 2025 due to consistent strategic execution, strong brand equity, and a promising financial outlook [22] - For investors seeking stability and consistent growth, RL presents a compelling investment opportunity [25]